Fingerprint
Dive into the research topics of 'Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer
Anita Schwandt, Tarek Mekhail, Balazs Halmos, Timothy O'Brien, Patrick C. Ma, Pingfu Fu, Percy Ivy, Afshin Dowlati
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations